Who is sponsoring NCT05489302?

NCT05489302 is sponsored by Al-Azhar University.

What drugs are being tested in NCT05489302?

Interventions in NCT05489302: Maxillary skeletal expander with protraction face mask with Alt-RAMEC protocol., Maxillary skeletal expander with protraction face mask with conventional protocol.

What condition does NCT05489302 study?

NCT05489302 studies Maxillary Protraction in Class III Adolescent After Using (MSE).

Is NCT05489302 still recruiting?

NCT05489302 is currently status unknown. Last updated 18 August 2023.

Last reviewed 2023-08-18 · How we verify

NCT05489302

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Two Protocol of Maxillary Protraction in Class III Adolescent After Using (MSE)

Status unknown NA Last updated 18 August 2023

What this trial tests

NA trial testing Maxillary skeletal expander with protraction face mask with Alt-RAMEC protocol. in Maxillary Protraction in Class III Adolescent After Using (MSE) in 42 participants. Status unknown.

Timeline

20 June 2022

Primary endpoint
30 December 2022

20 December 2023

Quick facts

Lead sponsor	Al-Azhar University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	42
Start date	20 June 2022
Primary completion	30 December 2022
Estimated completion	20 December 2023
Sites	1 location across Egypt

Drugs / interventions tested

Maxillary skeletal expander with protraction face mask with Alt-RAMEC protocol.
Maxillary skeletal expander with protraction face mask with conventional protocol

Conditions studied

Maxillary Protraction in Class III Adolescent After Using (MSE) — all drugs for Maxillary Protraction in Class III Adolescent After Using (MSE) →

Sponsor

Al-Azhar University

Who can join

Adults 13 to 17, any sex, with Maxillary Protraction in Class III Adolescent After Using (MSE). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study of this study is to compare two protocol of maxillary protraction in class III adolescent after using (MSE) Alt-RAMEC vs conventional rapid palatal expansion using cone beam computed tomography (CBCT)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Al-Azhar University trials

Trials by the same sponsor.

NCT06489327 — Comparing Two Doses of Oral Melatonin as Premedication in Children Undergoing Surgery · NA · recruiting
NCT07327918 — Effect of Epidural Needle Injection on Catheter Placement Success During Painless Labour · Phase 3 · not yet recruiting
NCT07500194 — Quad Helix vs RME for Posterior Cross-bite in Egyptian Children · NA · not yet recruiting
NCT07360756 — Ultrasonographic ONSD as a Predictor of PDPH in Spinal Anesthesia for Cesarean Delivery · not yet recruiting
NCT07343570 — Comparison of Quadratus Lumborum and Combined Groin Nerve Blocks for Postoperative Analgesia After Open Inguinal Hernia · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05489302 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Al-Azhar University
Last refreshed: 18 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05489302.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing